- Home
- SERA vs ANIX Comparison
SERA vs ANIX Comparison
Compare SERA & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SERA
- ANIX
- Stock Information
- Founded
- SERA 2008
- ANIX 1982
- Country
- SERA United States
- ANIX United States
- Employees
- SERA N/A
- ANIX N/A
- Industry
- SERA Precision Instruments
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- SERA Health Care
- ANIX Health Care
- Exchange
- SERA Nasdaq
- ANIX Nasdaq
- Market Cap
- SERA 90.6M
- ANIX 95.7M
- IPO Year
- SERA 2021
- ANIX 1987
- Fundamental
- Price
- SERA $3.25
- ANIX $4.19
- Analyst Decision
- SERA
- ANIX Strong Buy
- Analyst Count
- SERA 0
- ANIX 3
- Target Price
- SERA N/A
- ANIX $9.00
- AVG Volume (30 Days)
- SERA 44.5K
- ANIX 280.9K
- Earning Date
- SERA 11-05-2025
- ANIX 09-10-2025
- Dividend Yield
- SERA N/A
- ANIX N/A
- EPS Growth
- SERA N/A
- ANIX N/A
- EPS
- SERA N/A
- ANIX N/A
- Revenue
- SERA $108,000.00
- ANIX N/A
- Revenue This Year
- SERA $217.92
- ANIX N/A
- Revenue Next Year
- SERA $479.25
- ANIX N/A
- P/E Ratio
- SERA N/A
- ANIX N/A
- Revenue Growth
- SERA 0.94
- ANIX N/A
- 52 Week Low
- SERA $1.37
- ANIX $2.07
- 52 Week High
- SERA $9.13
- ANIX $4.98
- Technical
- Relative Strength Index (RSI)
- SERA 57.38
- ANIX 58.50
- Support Level
- SERA $3.11
- ANIX $4.21
- Resistance Level
- SERA $3.40
- ANIX $4.67
- Average True Range (ATR)
- SERA 0.18
- ANIX 0.34
- MACD
- SERA 0.00
- ANIX 0.04
- Stochastic Oscillator
- SERA 81.09
- ANIX 55.47
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.